Selenium and GPX4, a vital symbiosis

Free Radical Biology and Medicine

Volumn 127, Issue , 2018, Pages 153-159

  Friedmann Angeli, José Pedro ^a   Conrad, Marcus ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cell death; Cholesterol metabolism; Embryogenesis; Ferroptosis; Selenoproteins

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; GLUTATHIONE PEROXIDASE; MEVALONIC ACID; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SECISBP2 PROTEIN; SELENIUM; SELENOPROTEIN; SELENOPROTEIN N; SELENOPROTEIN T; SEPSECS PROTEIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; TRANSFER RNA; UNCLASSIFIED DRUG; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE;

3' UNTRANSLATED REGION; BIOSYNTHESIS; CHOLESTEROL METABOLISM; DISEASE ASSOCIATION; FERROPTOSIS; GENE INSERTION SEQUENCE; METABOLIC REGULATION; MUTATION; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ANIMAL; HUMAN; METABOLISM;

ANIMALS; GLUTATHIONE PEROXIDASE; HUMANS; SELENIUM; SELENOPROTEINS;

EID: 85043534009     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2018.03.001     Document Type: Review

References (79)

1. Berzelius, J.J., Lettre de M. Berzelius à M. Berthollet sur deux métaux nouveaux (Letter from Mr. Berzelius to Mr. Berthollet on two new metals). Ann. Chim. Phys. 7:2 (1818), 199–206.
2. Lobanov, A.V., Fomenko, D.E., Zhang, Y., Sengupta, A., Hatfield, D.L., Gladyshev, V.N., Evolutionary dynamics of eukaryotic selenoproteomes: large selenoproteomes may associate with aquatic life and small with terrestrial life. Genome Biol., 8(9), 2007, R198.
3. Reich, H.J., Hondal, R.J., Why nature chose selenium. ACS Chem. Biol. 11:4 (2016), 821–841.
4. Schweizer, U., Fradejas-Villar, N., Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism. FASEB J. 30:11 (2016), 3669–3681.
5. Berry, M.J., Banu, L., Chen, Y.Y., Mandel, S.J., Kieffer, J.D., Harney, J.W., Larsen, P.R., Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353:6341 (1991), 273–276.
6. Copeland, P.R., Fletcher, J.E., Carlson, B.A., Hatfield, D.L., Driscoll, D.M., A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 19:2 (2000), 306–314.
7. Tujebajeva, R.M., Copeland, P.R., Xu, X.M., Carlson, B.A., Harney, J.W., Driscoll, D.M., Hatfield, D.L., Berry, M.J., Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 1:2 (2000), 158–163.
8. Lee, B.J., Worland, P.J., Davis, J.N., Stadtman, T.C., Hatfield, D.L., Identification of a selenocysteyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon, UGA. J. Biol. Chem. 264:17 (1989), 9724–9727.
9. Kim, I.Y., Guimaraes, M.J., Zlotnik, A., Bazan, J.F., Stadtman, T.C., Fetal mouse selenophosphate synthetase 2 (SPS2): characterization of the cysteine mutant form overproduced in a baculovirus-insect cell system. Proc. Natl. Acad. Sci. USA 94:2 (1997), 418–421.
10. Xu, X.M., Carlson, B.A., Mix, H., Zhang, Y., Saira, K., Glass, R.S., Berry, M.J., Gladyshev, V.N., Hatfield, D.L., Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol., 5(1), 2007, e4.
11. Xu, X.M., Turanov, A.A., Carlson, B.A., Yoo, M.H., Everley, R.A., Nandakumar, R., Sorokina, I., Gygi, S.P., Gladyshev, V.N., Hatfield, D.L., Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc. Natl. Acad. Sci. USA 107:50 (2010), 21430–21434.
12. Lu, J., Zhong, L., Lonn, M.E., Burk, R.F., Hill, K.E., Holmgren, A., Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver. FASEB J. 23:8 (2009), 2394–2402.
13. Hatfield, D.L., Carlson, B.A., Xu, X.M., Mix, H., Gladyshev, V.N., Selenocysteine incorporation machinery and the role of selenoproteins in development and health. Prog. Nucleic Acid. Res. Mol. Biol. 81 (2006), 97–142.
14. Fordyce, F., Selenium geochemistry and health. Ambio 36:1 (2007), 94–97.
15. Schwarz, K., Foltz, C.M., Factor 3 activity of selenium compounds. J. Biol. Chem. 233:1 (1958), 245–251.
16. Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G., Hoekstra, W.G., Selenium: biochemical role as a component of glutathione peroxidase. Science 179:73 (1973), 588–590.
17. Flohe, L., Gunzler, W.A., Schock, H.H., Glutathione peroxidase: a selenoenzyme. FEBS Lett. 32:1 (1973), 132–134.
18. Kryukov, G.V., Castellano, S., Novoselov, S.V., Lobanov, A.V., Zehtab, O., Guigo, R., Gladyshev, V.N., Characterization of mammalian selenoproteomes. Science 300:5624 (2003), 1439–1443.
19. Moghadaszadeh, B., Petit, N., Jaillard, C., Brockington, M., Quijano Roy, S., Merlini, L., Romero, N., Estournet, B., Desguerre, I., Chaigne, D., Muntoni, F., Topaloglu, H., Guicheney, P., Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat. Genet. 29:1 (2001), 17–18.
20. Gladyshev, V.N., Arner, E.S., Berry, M.J., Brigelius-Flohe, R., Bruford, E.A., Burk, R.F., Carlson, B.A., Castellano, S., Chavatte, L., Conrad, M., Copeland, P.R., Diamond, A.M., Driscoll, D.M., Ferreiro, A., Flohe, L., Green, F.R., Guigo, R., Handy, D.E., Hatfield, D.L., Hesketh, J., Hoffmann, P.R., Holmgren, A., Hondal, R.J., Howard, M.T., Huang, K., Kim, H.Y., Kim, I.Y., Kohrle, J., Krol, A., Kryukov, G.V., Lee, B.J., Lee, B.C., Lei, X.G., Liu, Q., Lescure, A., Lobanov, A.V., Loscalzo, J., Maiorino, M., Mariotti, M., Sandeep Prabhu, K., Rayman, M.P., Rozovsky, S., Salinas, G., Schmidt, E.E., Schomburg, L., Schweizer, U., Simonovic, M., Sunde, R.A., Tsuji, P.A., Tweedie, S., Ursini, F., Whanger, P.D., Zhang, Y., Selenoprotein gene nomenclature. J. Biol. Chem. 291:46 (2016), 24036–24040.
21. Liu, J., Rozovsky, S., Membrane-bound selenoproteins. Antioxid. Redox Signal. 23:10 (2015), 795–813.
22. Rederstorff, M., Castets, P., Arbogast, S., Laine, J., Vassilopoulos, S., Beuvin, M., Dubourg, O., Vignaud, A., Ferry, A., Krol, A., Allamand, V., Guicheney, P., Ferreiro, A., Lescure, A., Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: a mammalian model for SEPN1-related myopathy. PLoS One, 6(8), 2011, e23094.
23. Schoenmakers, E., Agostini, M., Mitchell, C., Schoenmakers, N., Papp, L., Rajanayagam, O., Padidela, R., Ceron-Gutierrez, L., Doffinger, R., Prevosto, C., Luan, J., Montano, S., Lu, J., Castanet, M., Clemons, N., Groeneveld, M., Castets, P., Karbaschi, M., Aitken, S., Dixon, A., Williams, J., Campi, I., Blount, M., Burton, H., Muntoni, F., O'Donovan, D., Dean, A., Warren, A., Brierley, C., Baguley, D., Guicheney, P., Fitzgerald, R., Coles, A., Gaston, H., Todd, P., Holmgren, A., Khanna, K.K., Cooke, M., Semple, R., Halsall, D., Wareham, N., Schwabe, J., Grasso, L., Beck-Peccoz, P., Ogunko, A., Dattani, M., Gurnell, M., Chatterjee, K., Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120:12 (2010), 4220–4235.
24. Loh, K., Deng, H., Fukushima, A., Cai, X., Boivin, B., Galic, S., Bruce, C., Shields, B.J., Skiba, B., Ooms, L.M., Stepto, N., Wu, B., Mitchell, C.A., Tonks, N.K., Watt, M.J., Febbraio, M.A., Crack, P.J., Andrikopoulos, S., Tiganis, T., Reactive oxygen species enhance insulin sensitivity. Cell Metab. 10:4 (2009), 260–272.
25. Dumitrescu, A.M., Refetoff, S., The syndromes of reduced sensitivity to thyroid hormone. Biochim. Biophys. Acta 1830:7 (2013), 3987–4003.
26. Seeher, S., Atassi, T., Mahdi, Y., Carlson, B.A., Braun, D., Wirth, E.K., Klein, M.O., Reix, N., Miniard, A.C., Schomburg, L., Hatfield, D.L., Driscoll, D.M., Schweizer, U., Secisbp2 is essential for embryonic development and enhances selenoprotein expression. Antioxid. Redox Signal. 21:6 (2014), 835–849.
27. Agamy, O., Ben Zeev, B., Lev, D., Marcus, B., Fine, D., Su, D., Narkis, G., Ofir, R., Hoffmann, C., Leshinsky-Silver, E., Flusser, H., Sivan, S., Soll, D., Lerman-Sagie, T., Birk, O.S., Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy. Am. J. Hum. Genet. 87:4 (2010), 538–544.
28. Ben-Zeev, B., Hoffman, C., Lev, D., Watemberg, N., Malinger, G., Brand, N., Lerman-Sagie, T., Progressive cerebellocerebral atrophy: a new syndrome with microcephaly, mental retardation, and spastic quadriplegia. J. Med. Genet., 40(8), 2003, e96.
29. Anttonen, A.K., Hilander, T., Linnankivi, T., Isohanni, P., French, R.L., Liu, Y., Simonovic, M., Soll, D., Somer, M., Muth-Pawlak, D., Corthals, G.L., Laari, A., Ylikallio, E., Lahde, M., Valanne, L., Lonnqvist, T., Pihko, H., Paetau, A., Lehesjoki, A.E., Suomalainen, A., Tyynismaa, H., Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate. Neurology 85:4 (2015), 306–315.
30. Schoenmakers, E., Carlson, B., Agostini, M., Moran, C., Rajanayagam, O., Bochukova, E., Tobe, R., Peat, R., Gevers, E., Muntoni, F., Guicheney, P., Schoenmakers, N., Farooqi, S., Lyons, G., Hatfield, D., Chatterjee, K., Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis. J. Clin. Invest. 126:3 (2016), 992–996.
31. Jakupoglu, C., Przemeck, G.K., Schneider, M., Moreno, S.G., Mayr, N., Hatzopoulos, A.K., de Angelis, M.H., Wurst, W., Bornkamm, G.W., Brielmeier, M., Conrad, M., Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol. Cell. Biol. 25:5 (2005), 1980–1988.
32. Bondareva, A.A., Capecchi, M.R., Iverson, S.V., Li, Y., Lopez, N.I., Lucas, O., Merrill, G.F., Prigge, J.R., Siders, A.M., Wakamiya, M., Wallin, S.L., Schmidt, E.E., Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome. Free Radic. Biol. Med. 43:6 (2007), 911–923.
33. Kudin, A.P., Baron, G., Zsurka, G., Hampel, K.G., Elger, C.E., Grote, A., Weber, Y., Lerche, H., Thiele, H., Nurnberg, P., Schulz, H., Ruppert, A.K., Sander, T., Cheng, Q., Arner, E.S., Schomburg, L., Seeher, S., Fradejas-Villar, N., Schweizer, U., Kunz, W.S., Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy. Free Radic. Biol. Med. 106 (2017), 270–277.
34. Sibbing, D., Pfeufer, A., Perisic, T., Mannes, A.M., Fritz-Wolf, K., Unwin, S., Sinner, M.F., Gieger, C., Gloeckner, C.J., Wichmann, H.E., Kremmer, E., Schafer, Z., Walch, A., Hinterseer, M., Nabauer, M., Kaab, S., Kastrati, A., Schomig, A., Meitinger, T., Bornkamm, G.W., Conrad, M., von Beckerath, N., Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur. Heart J. 32:9 (2011), 1121–1133.
35. Conrad, M., Jakupoglu, C., Moreno, S.G., Lippl, S., Banjac, A., Schneider, M., Beck, H., Hatzopoulos, A.K., Just, U., Sinowatz, F., Schmahl, W., Chien, K.R., Wurst, W., Bornkamm, G.W., Brielmeier, M., Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 24:21 (2004), 9414–9423.
36. Prasad, R., Chan, L.F., Hughes, C.R., Kaski, J.P., Kowalczyk, J.C., Savage, M.O., Peters, C.J., Nathwani, N., Clark, A.J., Storr, H.L., Metherell, L.A., Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J. Clin. Endocrinol. Metab. 99:8 (2014), E1556–E1563.
37. Smith, A.C., Mears, A.J., Bunker, R., Ahmed, A., MacKenzie, M., Schwartzentruber, J.A., Beaulieu, C.L., Ferretti, E., Consortium, F.C., Majewski, J., Bulman, D.E., Celik, F.C., Boycott, K.M., Graham, G.E., Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type spondylometaphyseal dysplasia. J. Med. Genet. 51:7 (2014), 470–474.
38. Yant, L.J., Ran, Q., Rao, L., Van Remmen, H., Shibatani, T., Belter, J.G., Motta, L., Richardson, A., Prolla, T.A., The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34:4 (2003), 496–502.
39. Imai, H., Hirao, F., Sakamoto, T., Sekine, K., Mizukura, Y., Saito, M., Kitamoto, T., Hayasaka, M., Hanaoka, K., Nakagawa, Y., Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem. Biophys. Res. Commun. 305:2 (2003), 278–286.
40. Ingold, I., Berndt, C., Schmitt, S., Doll, S., Poschmann, G., Buday, K., Roveri, A., Peng, X., Porto Freitas, F., Seibt, T., Mehr, L., Aichler, M., Walch, A., Lamp, D., Jastroch, M., Miyamoto, S., Wurst, W., Ursini, F., Arner, E.S.J., Fradejas-Villar, N., Schweizer, U., Zischka, H., Friedmann Angeli, J.P., Conrad, M., Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172:3 (2018), 409–422e21.
41. Green, D.R., An element of life. Cell 172:3 (2018), 389–390.
42. Ronchi, J.A., Figueira, T.R., Ravagnani, F.G., Oliveira, H.C., Vercesi, A.E., Castilho, R.F., A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities. Free Radic. Biol. Med. 63 (2013), 446–456.
43. Bosl, M.R., Takaku, K., Oshima, M., Nishimura, S., Taketo, M.M., Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. USA 94:11 (1997), 5531–5534.
44. Kumaraswamy, E., Carlson, B.A., Morgan, F., Miyoshi, K., Robinson, G.W., Su, D., Wang, S., Southon, E., Tessarollo, L., Lee, B.J., Gladyshev, V.N., Hennighausen, L., Hatfield, D.L., Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol. Cell. Biol. 23:5 (2003), 1477–1488.
45. Sengupta, A., Carlson, B.A., Weaver, J.A., Novoselov, S.V., Fomenko, D.E., Gladyshev, V.N., Hatfield, D.L., A functional link between housekeeping selenoproteins and phase II enzymes. Biochem. J. 413:1 (2008), 151–161.
46. Carlson, B.A., Novoselov, S.V., Kumaraswamy, E., Lee, B.J., Anver, M.R., Gladyshev, V.N., Hatfield, D.L., Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J. Biol. Chem. 279:9 (2004), 8011–8017.
47. Nelson, S.M., Shay, A.E., James, J.L., Carlson, B.A., Urban, J.F. Jr., Prabhu, K.S., Selenoprotein expression in macrophages is critical for optimal clearance of parasitic helminth Nippostrongylus brasiliensis. J. Biol. Chem. 291:6 (2016), 2787–2798.
48. Luchman, H.A., Villemaire, M.L., Bismar, T.A., Carlson, B.A., Jirik, F.R., Prostate epithelium-specific deletion of the selenocysteine tRNA gene Trsp leads to early onset intraepithelial neoplasia. Am. J. Pathol. 184:3 (2014), 871–877.
49. Suzuki, T., Kelly, V.P., Motohashi, H., Nakajima, O., Takahashi, S., Nishimura, S., Yamamoto, M., Deletion of the selenocysteine tRNA gene in macrophages and liver results in compensatory gene induction of cytoprotective enzymes by Nrf2. J. Biol. Chem. 283:4 (2008), 2021–2030.
50. Kawatani, Y., Suzuki, T., Shimizu, R., Kelly, V.P., Yamamoto, M., Nrf2 and selenoproteins are essential for maintaining oxidative homeostasis in erythrocytes and protecting against hemolytic anemia. Blood 117:3 (2011), 986–996.
51. Conrad, M., Schweizer, U., Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid. Redox Signal. 12:7 (2010), 851–865.
52. Kasaikina, M.V., Hatfield, D.L., Gladyshev, V.N., Understanding selenoprotein function and regulation through the use of rodent models. Biochim. Biophys. Acta 1823:9 (2012), 1633–1642.
53. Conrad, M., Schweizer, U., Mouse models that target individual selenoproteins. Hatfield, D.L., Schweizer, U., Tsuji, P.A., Gladyshev, V.N., (eds.) Selenium: Its Molecular Biology and Role in Human Health, 2016, Springer International Publishing, Cham, 567–578.
54. Boukhzar, L., Hamieh, A., Cartier, D., Tanguy, Y., Alsharif, I., Castex, M., Arabo, A., El Hajji, S., Bonnet, J.J., Errami, M., Falluel-Morel, A., Chagraoui, A., Lihrmann, I., Anouar, Y., Selenoprotein T. exerts an essential oxidoreductase activity that protects dopaminergic neurons in mouse models of Parkinson's disease. Antioxid. Redox Signal. 24:11 (2016), 557–574.
55. Friedmann Angeli, J.P., Proneth, B., Conrad, M., Glutathione peroxidase 4 and ferroptosis. Hatfield, D.L., Schweizer, U., Tsuji, P.A., Gladyshev, V.N., (eds.) Selenium: Its Molecular Biology and Role in Human Health, 2016, Springer International Publishing, New York, 511–521.
56. Wirth, E.K., Conrad, M., Winterer, J., Wozny, C., Carlson, B.A., Roth, S., Schmitz, D., Bornkamm, G.W., Coppola, V., Tessarollo, L., Schomburg, L., Kohrle, J., Hatfield, D.L., Schweizer, U., Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J. 24:3 (2010), 844–852.
57. Wirth, E.K., Bharathi, B.S., Hatfield, D., Conrad, M., Brielmeier, M., Schweizer, U., Cerebellar hypoplasia in mice lacking selenoprotein biosynthesis in neurons. Biol. Trace Elem. Res. 158:2 (2014), 203–210.
58. Carlson, B.A., Tobe, R., Yefremova, E., Tsuji, P.A., Hoffmann, V.J., Schweizer, U., Gladyshev, V.N., Hatfield, D.L., Conrad, M., Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 9 (2016), 22–31.
59. Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G.W., Kopf, M., T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212:4 (2015), 555–568.
60. Shrimali, R.K., Irons, R.D., Carlson, B.A., Sano, Y., Gladyshev, V.N., Park, J.M., Hatfield, D.L., Selenoproteins mediate T cell immunity through an antioxidant mechanism. J. Biol. Chem. 283:29 (2008), 20181–20185.
61. Sengupta, A., Lichti, U.F., Carlson, B.A., Ryscavage, A.O., Gladyshev, V.N., Yuspa, S.H., Hatfield, D.L., Selenoproteins are essential for proper keratinocyte function and skin development. PLoS One, 5(8), 2010, e12249.
62. Sengupta, A., Lichti, U.F., Carlson, B.A., Cataisson, C., Ryscavage, A.O., Mikulec, C., Conrad, M., Fischer, S.M., Hatfield, D.L., Yuspa, S.H., Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J. Invest. Dermatol. 133:7 (2013), 1731–1741.
63. Canli, O., Alankus, Y.B., Grootjans, S., Vegi, N., Hultner, L., Hoppe, P.S., Schroeder, T., Vandenabeele, P., Bornkamm, G.W., Greten, F.R., Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127:1 (2016), 139–148.
64. Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E.K., Culmsee, C., Plesnila, N., Kremmer, E., Radmark, O., Wurst, W., Bornkamm, G.W., Schweizer, U., Conrad, M., Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8:3 (2008), 237–248.
65. Friedmann Angeli, J.P., Schneider, M., Proneth, B., Tyurina, Y.Y., Tyurin, V.A., Hammond, V.J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., Basavarajappa, D., Radmark, O., Kobayashi, S., Seibt, T., Beck, H., Neff, F., Esposito, I., Wanke, R., Forster, H., Yefremova, O., Heinrichmeyer, M., Bornkamm, G.W., Geissler, E.K., Thomas, S.B., Stockwell, B.R., O'Donnell, V.B., Kagan, V.E., Schick, J.A., Conrad, M., Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16:12 (2014), 1180–1191.
66. Conrad, M., Angeli, J.P., Vandenabeele, P., Stockwell, B.R., Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 15:5 (2016), 348–366.
67. Doll, S., Proneth, B., Tyurina, Y.Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., Prokisch, H., Trumbach, D., Mao, G., Qu, F., Bayir, H., Fullekrug, J., Scheel, C.H., Wurst, W., Schick, J.A., Kagan, V.E., Angeli, J.P., Conrad, M., ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13:1 (2017), 91–98.
68. Kagan, V.E., Mao, G., Qu, F., Angeli, J.P., Doll, S., Croix, C.S., Dar, H.H., Liu, B., Tyurin, V.A., Ritov, V.B., Kapralov, A.A., Amoscato, A.A., Jiang, J., Anthonymuthu, T., Mohammadyani, D., Yang, Q., Proneth, B., Klein-Seetharaman, J., Watkins, S., Bahar, I., Greenberger, J., Mallampalli, R.K., Stockwell, B.R., Tyurina, Y.Y., Conrad, M., Bayir, H., Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13:1 (2017), 81–90.
69. Wenzel, S.E., Tyurina, Y.Y., Zhao, J., St. Croix, C.M., Dar, H.H., Mao, G., Tyurin, V.A., Anthonymuthu, T.S., Kapralov, A.A., Amoscato, A.A., Mikulska-Ruminska, K., Shrivastava, I.H., Kenny, E.M., Yang, Q., Rosenbaum, J.C., Sparvero, L.J., Emlet, D.R., Wen, X., Minami, Y., Qu, F., Watkins, S.C., Holman, T.R., VanDemark, A.P., Kellum, J.A., Bahar, I., Bayir, H., Kagan, V.E., PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell 171:3 (2017), 628–641 e26.
70. Jelinek, A., Heyder, L., Daude, M., Plessner, M., Krippner, S., Grosse, R., Diederich, W.E., Culmsee, C., Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis. Free Radic. Biol. Med. 117 (2018), 45–57.
71. Yang, W.S., Kim, K.J., Gaschler, M.M., Patel, M., Shchepinov, M.S., Stockwell, B.R., Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. USA 113:34 (2016), E4966–E4975.
72. Holstein, S.A., Hohl, R.J., Isoprenoids: remarkable diversity of form and function. Lipids 39:4 (2004), 293–309.
73. Schweizer, U., Bohleber, S., Fradejas-Villar, N., The modified base isopentenyladenosine and its derivatives in tRNA. RNA Biol. 14:9 (2017), 1197–1208.
74. Moosmann, B., Behl, C., Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway. Trends Cardiovasc. Med. 14:7 (2004), 273–281.
75. Moosmann, B., Behl, C., Selenoprotein synthesis and side-effects of statins. Lancet 363:9412 (2004), 892–894.
76. Russo, M.W., Hoofnagle, J.H., Gu, J., Fontana, R.J., Barnhart, H., Kleiner, D.E., Chalasani, N., Bonkovsky, H.L., Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 60:2 (2014), 679–686.
77. Shimada, K., Skouta, R., Kaplan, A., Yang, W.S., Hayano, M., Dixon, S.J., Brown, L.M., Valenzuela, C.A., Wolpaw, A.J., Stockwell, B.R., Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12:7 (2016), 497–503.
78. Mas, E., Mori, T.A., Coenzyme Q(10) and statin myalgia: what is the evidence?. Curr. Atheroscler. Rep. 12:6 (2010), 407–413.
79. Viswanathan, V.S., Ryan, M.J., Dhruv, H.D., Gill, S., Eichhoff, O.M., Seashore-Ludlow, B., Kaffenberger, S.D., Eaton, J.K., Shimada, K., Aguirre, A.J., Viswanathan, S.R., Chattopadhyay, S., Tamayo, P., Yang, W.S., Rees, M.G., Chen, S., Boskovic, Z.V., Javaid, S., Huang, C., Wu, X., Tseng, Y.Y., Roider, E.M., Gao, D., Cleary, J.M., Wolpin, B.M., Mesirov, J.P., Haber, D.A., Engelman, J.A., Boehm, J.S., Kotz, J.D., Hon, C.S., Chen, Y., Hahn, W.C., Levesque, M.P., Doench, J.G., Berens, M.E., Shamji, A.F., Clemons, P.A., Stockwell, B.R., Schreiber, S.L., Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547:7664 (2017), 453–457 (mouse mammary tumor virus).